Switching to a Second Generation TKI in Chronic Myeloid Leukemia Patients with Late Suboptimal Response with Imatinib Obtained Better Molecular Responses That the
Services
Services
Date issued
2012Journal title
Blood
Type of content
Publicación de congreso
